BridgeMD
Tests treatment safety and results for Chemotherapy Induced Neuropathic Pain
Official title Efficacy and Safety Study of Halneuron in the Treatment of Chemotherapy-Induced Neuropathic Pain
ClinicalTrials.gov ID: NCT06848348
What this study is testing
What is Halneuron?
Halneuron is an investigational medicine, given as an injection under the skin, being studied as a potential treatment for chemotherapy induced neuropathic pain.
Plain-language explanation of the investigational treatment - it is being studied and is not an approved or proven therapy. The study team can confirm the details.
- What it's testing
- A randomized study to determine safety and efficacy of a series of subcutaneous (SC) injections of HAL in patients with CINP, compared to matching placebo injections. After that, subjects may have the option to enter an Open Label extension phase, where available, in which all subjects will receive Halneuron.
- Phase 2: a mid-size study of how well it works
- You might receive a placebo (an inactive treatment) instead of the study drug, decided by chance.
A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.
Who can take part
Ages 18 and older
You may be able to join if
- Male or female patients aged ≥18 years.
- Neuropathic pain has been present and is attributed to platinum and/or taxane chemotherapy.
- Patient has received a cancer chemotherapy regimen that included taxanes and/or platinum and has no active or discernible disease progression.
You likely can't join if
- Current neuropathic pain with symptoms similar to CINP but attributed to causes other than platinum or taxane chemotherapy.
- Patients who have received HAL at any time prior to screening.
The study team makes the final eligibility decision.
Where it's taking place
- Sheffield, Alabama, United States
- Glendale, Arizona, United States
- Phoenix, Arizona, United States
- Fair Oaks, California, United States
- Fountain Valley, California, United States
- Los Angeles, California, United States
- Santa Rosa, California, United States
- Wheat Ridge, Colorado, United States
- Jacksonville, Florida, United States
- Lakeland, Florida, United States
- Orlando, Florida, United States
- Port Charlotte, Florida, United States
- Tampa, Florida, United States
- Gurnee, Illinois, United States
- Lake Charles, Louisiana, United States
- Fenton, Missouri, United States
- Las Vegas, Nevada, United States
- Garden City, New York, United States
- Williamsville, New York, United States
- Winston-Salem, North Carolina, United States
+ 4 more site(s).
Questions & answers
Do participants get paid in this trial?
This listing doesn't specify compensation. Many trials still reimburse travel or offer a stipend, so it's worth asking the study team when you connect.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part - confirm specifics with the study team.
How long does this study last?
The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.
Who can join this trial?
This study is enrolling all sexes, 18 years and older. The study team makes the final eligibility decision.
Where is this trial taking place?
Study sites include Sheffield, Alabama, United States; Glendale, Arizona, United States; Phoenix, Arizona, United States; Fair Oaks, California, United States; Fountain Valley, California, United States; Los Angeles, California, United States and 18 more location(s). Enter your location above to see the nearest site and check your eligibility.
Explore other conditions
BridgeMD is an information and trial-matching tool - not medical advice, and not the study sponsor. Details come from ClinicalTrials.gov; the study team decides eligibility.